+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fetal Bovine Serum Market Size, Share & Trends Analysis Report By Application (Drug Discovery, In-vitro Fertilization, Vaccine Production, Cell-based Research, Diagnostics, Others), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5830985
Description Jump to:
The global fetal bovine serum market size is expected to reach USD 4.56 billion by 2030, registering a CAGR of 14.1% from 2023 to 2030. One of the key market-driving factors includes the remarkable growth of the applications of cell & tissue culture in diagnostics, research, pharmaceutical, and biotech industries.

Factors contributing to the growth of the fetal bovine serum (FBS) market include the increasing use of cell-based assays in drug discovery and development, the rising demand for biologics and biosimilars, and the growing investment in regenerative medicine and stem cell research. However, there are concerns about the ethical and environmental implications of using FBS, and alternative serum-free media and supplements are being developed to meet these concerns.

The market is offering manufacturers lucrative growth prospects due to technological development and company portfolio expansion in the serum space. Fetal bovine serum is in exceptionally high demand as a result of the pace at which R&D operations are developing technology. Fetal bovine serum has a wide range of uses, which motivates the biopharmaceutical industry to create therapies and medications that use animals as their primary ingredient. The use of animal hosts for the production of drugs and vaccines has a number of benefits, including low-cost and high-volume production of the final product. This element is expected to fuel market expansion in the years to come.

Furthermore, the pandemic has positively impacted the FBS market. It has led to a surge in demand for vaccines and therapeutics, which has increased the demand for FBS as an important component in cell culture media. This has led to further strain on the already limited supply of FBS. To address this shortage, companies are exploring alternative sources of animal serum and developing serum-free media for cell culture. Moreover, ethical concerns regarding the use of animal-derived products, including FBS, have increased during the pandemic. This has led to a growing demand for plant-based or synthetic alternatives to FBS. The development of such alternatives is still in the early stages, but it is likely to gain momentum in the coming years.

Fetal Bovine Serum Market Report Highlights

  • Based on application, the vaccine production segment dominated the market with a share of 28.4% in 2022. The market is expected to dominate due to the increasing adoption of fetal bovine serum in cell-based research by the pharmaceutical and biotechnology industry
  • By end-user, the pharmaceutical and biotechnology segment held the largest market share of 40.4% in 2022 owing to the wide usage of fetal bovine serum in developing new drugs and human & animal vaccines
  • The segment of CMOs and CROs is expected to continue growing lucratively with a CAGR of 15.6% from 2023 to 2030, as the demand for outsourced manufacturing and research services is increasing in the biopharmaceutical industry
  • North America dominated the global market with a 38.0% share in 2022, due to the increasing demand for fetal serum media and the presence of key players in the market
  • Asia Pacific is anticipated to register the fastest CAGR of 15.6% from 2023 to 2030. This is due to the increasing investments in cell culture products in the region, especially in the emerging economies


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Expansion of biopharmaceutical industry in developing countries
3.3.1.2. Increasing R&D activities and expenditure for introduction of new biopharmaceuticals
3.3.1.3. Increasing application of FBS in drug discovery, cell culture and human & animal vaccine production
3.3.2. Market Restraint Analysis
3.3.2.1. Presence of Alternatives
3.4. COVID-19 Impact
3.5. Industry Analysis Tools
3.5.1. Porter's Five Forces Analysis
3.5.2. Macroeconomic Analysis
Chapter 4. Fetal Bovine Serum Market: Application Analysis
4.1. Fetal Bovine Serum Market: Application Market Share Analysis
4.2. Fetal Bovine Serum Market Estimates & Forecast, By Application (USD Million)
4.3. Drug Discovery
4.3.1. Global Drug Discovery Market, 2018 - 2030 (USD Million)
4.4. In-vitro Fertilization
4.4.1. Global In-vitro Fertilization Process Market, 2018 - 2030 (USD Million)
4.5. Vaccine Production
4.5.1. Global Vaccine Production Market, 2018 - 2030 (USD Million)
4.6. Cell-based Research
4.6.1. Global Cell-based Research Market, 2018 - 2030 (USD Million)
4.7. Diagnostics
4.7.1. Global Diagnostics Market, 2018 - 2030 (USD Million)
4.8. Others
4.8.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 5. Fetal Bovine Serum Market: End-User Business Analysis
5.1. Fetal Bovine Serum Market: End-User Market Share Analysis
5.2. Fetal Bovine Serum Market Estimates & Forecast, By End-User (USD Million)
5.3. Pharmaceutical & Biotechnology Companies
5.3.1. Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
5.4. Contract Research Organizations (CRO)
5.4.1. Global Contract Research Organizations (CRO) Market, 2018 - 2030 (USD Million)
5.5. Academic and Research Organizations
5.5.1. Global Academic and Research Organizations Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Global Others Market, 2018 - 2030 (USD Million)
Chapter 6. Fetal Bovine Serum Market: Regional Business Analysis
6.1. Fetal Bovine Serum Market Share By Region, 2022 & 2030
6.2. North America
6.2.1. North America Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. UK Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Germany Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. France Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Italy Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Spain Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Denmark Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Sweden Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Norway Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Japan Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. China Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. India Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Australia Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4.6. South Korea
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. South Korea Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Thailand Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Brazil Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Mexico Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Argentina Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.6. MEA
6.6.1. MEA Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. South Africa Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Saudi Arabia Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. UAE Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Kuwait Fetal Bovine Serum Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Profiles/Listing
7.3.1. Thermo Fisher Scientific Inc.
7.3.1.1. Overview
7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.1.3. Product Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Sartorius AG
7.3.2.1. Overview
7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.2.3. Product Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Danaher Corporation
7.3.3.1. Overview
7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.3.3. Product Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Merck KGaA
7.3.4.1. Overview
7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.4.3. Product Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. HiMedia Laboratories
7.3.5.1. Overview
7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.5.3. Product Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Bio-Techne
7.3.6.1. Overview
7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.6.3. Product Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. PAN-Biotech
7.3.7.1. Overview
7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.7.3. Product Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Atlas Biologicals, Inc.
7.3.8.1. Overview
7.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.8.3. Product Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Rocky Mountain Biologicals
7.3.9.1. Overview
7.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.9.3. Product Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Biowest
7.3.10.1. Overview
7.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.3.10.3. Product Benchmarking
7.3.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 4 Global fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 5 Global fetal bovine serum market, by region, 2018 - 2030 (USD million)
Table 6 North America fetal bovine serum market, by country, 2018 - 2030 (USD million)
Table 7 North America fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 8 North America fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 9 U.S. fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 10 U.S. fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 11 Canada fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 12 Canada fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 13 Europe fetal bovine serum market, by country, 2018 - 2030 (USD million)
Table 14 Europe fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 15 Europe fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 16 Germany fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 17 Germany fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 18 UK fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 19 UK fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 20 France fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 21 France fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 22 Italy fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 23 Italy fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 24 Spain fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 25 Spain fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 26 Denmark fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 27 Denmark fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 28 Sweden fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 29 Sweden fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 30 Norway fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 31 Norway fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 32 Asia Pacific fetal bovine serum market, by country, 2018 - 2030 (USD million)
Table 33 Asia Pacific fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 34 Asia Pacific fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 35 Japan fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 36 Japan fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 37 China fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 38 China fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 39 India fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 40 India fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 41 Australia fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 42 Australia fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 43 South Korea fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 44 South Korea fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 45 Thailand fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 46 Thailand fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 47 Latin America fetal bovine serum market, by country, 2018 - 2030 (USD million)
Table 48 Latin America fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 49 Latin America fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 50 Brazil fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 51 Brazil fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 52 Mexico fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 53 Mexico fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 54 Argentina fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 55 Argentina fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 56 Middle East & Africa fetal bovine serum market, by country, 2018 - 2030 (USD million)
Table 57 Middle East & Africa fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 58 Middle East & Africa fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 59 South Africa fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 60 South Africa fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 61 Saudi Arabia fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 62 Saudi Arabia fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 63 UAE fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 64 UAE fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 65 Kuwait fetal bovine serum market, by application, 2018 - 2030 (USD million)
Table 66 Kuwait fetal bovine serum market, by end-user, 2018 - 2030 (USD million)
Table 67 Participant's overview
Table 68 Financial performance
Table 69 Key companies undergoing expansions
Table 70 Key companies undergoing acquisitions
Table 71 Key companies undergoing collaborations
Table 72 Key companies launching new types/services
Table 73 Key companies undertaking other strategies
List of Figures
Fig. 1 fetal bovine serum market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market outlook
Fig. 13 Related/ancillary market outlook
Fig. 14 Fetal Bovine Serum - Industry value chain analysis
Fig. 15 fetal bovine serum market driver analysis
Fig. 16 fetal bovine serum market restraint analysis
Fig. 17 fetal bovine serum market: Porter's analysis
Fig. 18 fetal bovine serum market: PESTLE analysis
Fig. 19 fetal bovine serum market: Application outlook and key takeaways
Fig. 20 fetal bovine serum market: Application market share analysis, 2022 - 2030
Fig. 21 Global drug discovery market, 2018 - 2030 (USD million)
Fig. 22 Global in-vitro fertilization market, 2018 - 2030 (USD million)
Fig. 23 Global vaccine production market, 2018 - 2030 (USD million)
Fig. 24 Global cell-based research market, 2018 - 2030 (USD million)
Fig. 25 Global diagnostics market, 2018 - 2030 (USD million)
Fig. 26 Global others market, 2018 - 2030 (USD million)
Fig. 27 fetal bovine serum market: End-user outlook and key takeaways
Fig. 28 fetal bovine serum market: End-user market share analysis, 2022 - 2030
Fig. 29 Global pharmaceutical & biotechnology companies market, 2018 - 2030 (USD million)
Fig. 30 Global contract research organizations (CROs) market, 2018 - 2030 (USD million)
Fig. 31 Global academic and research organizations market, 2018 - 2030 (USD million)
Fig. 32 Regional marketplace: Key takeaways
Fig. 33 Regional marketplace: Key takeaways
Fig. 34 North America fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 35 U.S. key country dynamics
Fig. 36 U.S. fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 37 Canada key country dynamics
Fig. 38 Canada fetal bovine serum market, 2018 - 2030 (USD million)
Fig. 39 Europe fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 40 Germany key country dynamics
Fig. 41 Germany fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 42 UK key country dynamics
Fig. 43 UK fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 44 France key country dynamics
Fig. 45 France fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 46 Italy key country dynamics
Fig. 47 Italy fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 48 Spain key country dynamics
Fig. 49 Spain fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 54 Norway key country dynamics
Fig. 55 Norway fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 56 Asia-Pacific fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 57 Japan key country dynamics
Fig. 58 Japan fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 59 China key country dynamics
Fig. 60 China fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 61 India key country dynamics
Fig. 62 India fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 63 Australia key country dynamics
Fig. 64 Australia fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 65 Thailand key country dynamics
Fig. 66 Thailand fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 67 South Korea key country dynamics
Fig. 68 South Korea fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 69 Latin America fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 70 Brazil key country dynamics
Fig. 71 Brazil fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 72 Mexico key country dynamics
Fig. 73 Mexico fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 74 Argentina key country dynamics
Fig. 75 Argentina fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 76 MEA fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 77 South Africa key country dynamics
Fig. 78 South Africa fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 79 Saudi Arabia key country dynamics
Fig. 80 Saudi Arabia fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 81 UAE key country dynamics
Fig. 82 UAE fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 83 Kuwait key country dynamics
Fig. 84 Kuwait fetal bovine serum market estimates and forecast, 2018 - 2030 (USD million)
Fig. 85 Key company categorization
Fig. 86 Company market positioning
Fig. 87 Market participant categorization
Fig. 88 Strategy framework

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Danaher Corporation
  • Merck KGaA
  • HiMedia Laboratories
  • Bio-Techne
  • PAN-Biotech
  • Atlas Biologicals, Inc.
  • Rocky Mountain Biologicals
  • Biowest

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1.57 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.56 Billion
Compound Annual Growth Rate14.1%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Fetal Bovine Serum Market by Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum), Application (Cell Culture Media, Diagnostics, Drug Discovery), End-User - Forecast 2024-2030 - Product Image

Global Fetal Bovine Serum Market by Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum), Application (Cell Culture Media, Diagnostics, Drug Discovery), End-User - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Fetal Bovine Serum Global Market Report 2024 - Product Image

Fetal Bovine Serum Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Defined Fetal Bovine Serum Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Defined Fetal Bovine Serum Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 115 Pages
  • Global
From
Fetal Bovine Serum Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology - Product Image

Fetal Bovine Serum Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

  • Report
  • 107 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.